Manufacturer to warn of fatal adverse reactions from blood-clotting drug and anaesthetic mix-ups A letter from Pfizer cautions healthcare professionals to use extreme caution when storing, handling and administrating IV formulations of tranexamic acid.…
GPhC announces 6% rise in registration fees From September 2026, pharmacist renewal fees will increase by £17 a year to £310, pharmacy technician fees by £8 to £146, and pharmacy premises fees by £25 to £441.…
New training standards for overseas pharmacists to include prescribing Proposed changes to training standards for internationally qualified pharmacists could replace the current registration routes with a single year of integrated academic learning and learning in practice.…
Pharmacists ‘perfectly placed’ to deliver nationally commissioned weight-loss service, MPs told Attendees of the Health and Social Care Committee session emphasised the importance of “wrap-around care” alongside prescribing GLP-1 medicines.…
Additional Responsible Pharmacist requirements would make pharmacy practice ‘more difficult’, says RPS In response to a General Pharmaceutical Council consultation, the Royal Pharmaceutical Society said that additional criteria for Responsible Pharmacists could undermine the delivery of services.…
Global regulators set out principles for safe AI across the medicines lifecycle From discovery to manufacturing and post-marketing surveillance, new joint principles from the European Medicines Agency and US Food and Drug Administration are aimed to ensure that AI in medicines development is human-centred, risk-based and transparent.…
National pharmacy board meetings: February 2026 A summary from the final meetings of the national pharmacy boards before the Society’s transition to become the Royal College of Pharmacy.…
Privy Council approves Royal Charter changes The Royal Pharmaceutical Society will become the Royal College of Pharmacy on 15 April 2026 following King Charles III’s approval.…
EMA proposes modifying pre-existing clinical trials during public health emergencies Draft guidance has suggested trial adaptations, including changing endpoints, introducing new patient cohorts, adding new trial arms and adapting randomisation.…
Regulators set out support for in-orbit pharmaceutical manufacturing In a joint statement, UK regulators said that the production of materials and products in space have the potential to offer higher quality medicines compared with those made on Earth.…
